about
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to m...
Read More
35.56
-1.38
(-3.74%)
1.1M
XNAS Volume
XNAS 12 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Harrow Health Inc is on 18 Mar 2026 for the purpose of Harrow Inc Fourth Quarter Earnings Conference Call for 2025
See details
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks have medium quality and momentum.Their expensive valuations suggest caution
View Similar
Embed DVM
Harrow Health Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..